Roles of Transmembrane Protein 119 in the Effects of Transforming Growth Factor-β on Mouse Bone Cells
Experimental and Clinical Endocrinology & Diabetes · 01.05.2025 · 133 (05) · 246-252
DOI: 10.1055/a-2555-4543 ↗Kurz gefasst
Fachartikel in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.05.2025. Verfasst von Ayaka Yamada und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Regenerative Medicine, Faculty of Medicine, Kindai University, Osakasayama, Japan. Hauptthemen laut MEDLINE: Membrane Proteins, Osteoblasts, Transforming Growth Factor beta, Osteogenesis. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Salt Science Research Foundation, Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
Transforming growth factor-β (TGF-β), a local growth factor, is essential for bone remodeling; when administered in bone tissues, it stimulates bone formation. On the other hand, transmembrane protein 119 (Tmem119) is a crucial factor for osteoblastic bone formation related to the TGF-β signaling molecule, Smad3. However, the role of Tmem119 in TGF-β-mediated effects on osteoblasts and osteoclasts remains unclear. The function of Tmem119 in TGF-β-mediated effects was examined for osteoblastic differentiation, bone matrix protein expression, and osteoclast formation in mouse osteoblasts, adipose tissue-derived stromal cells, and bone marrow cells from wild-type and Tmem119-deficient mice. Tmem119 deficiency significantly reversed the TGF-β-induced expressions of type I collagen and matrix-Gla protein (MGP) in mouse osteoblasts but did not affect TGF-β-suppressed alkaline phosphatase activity in mouse adipose tissue-derived stromal cells, even when TGF-β could suppress alkaline phosphatase (ALP) activity in mouse osteoblasts regardless of Tmem119 deficiency. Tmem119 deficiency significantly reduced osteoclast formation and Nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1) mRNA levels in mouse bone marrow cells. Tmem119 is involved in regulating type I collagen and MGP expressions and TGF-β-induced osteoclast formation, but does not affect TGF-β-suppressed osteoblastic differentiation in mouse cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Regenerative Medicine, Faculty of Medicine, Kindai University, Osakasayama, Japan.
Förderung
- Salt Science Research Foundation
- Ministry of Education, Culture, Sports, Science and Technology
Zitieren
APA
Yamada, A., Kawao, N., Mizukami, Y., & Kaji, H. (2025). Roles of Transmembrane Protein 119 in the Effects of Transforming Growth Factor-β on Mouse Bone Cells. Experimental and Clinical Endocrinology & Diabetes, 133(05), 246-252. https://doi.org/10.1055/a-2555-4543
Vancouver
Yamada A, Kawao N, Mizukami Y, Kaji H. Roles of Transmembrane Protein 119 in the Effects of Transforming Growth Factor-β on Mouse Bone Cells. Experimental and Clinical Endocrinology & Diabetes. 2025;133(05):246-252. doi:10.1055/a-2555-4543
BibTeX
@article{Yamada2025,
author = {Yamada, Ayaka and Kawao, Naoyuki and Mizukami, Yuya and Kaji, Hiroshi},
title = {Roles of Transmembrane Protein 119 in the Effects of Transforming Growth Factor-β on Mouse Bone Cells},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2025},
volume = {133},
number = {05},
pages = {246--252},
doi = {10.1055/a-2555-4543}
}
EUVIMED